Home » Newsletters » BioWorld Science

BioWorld Science

March 27, 2009

View Archived Issues

Mitomycin C may prevent bladder tumor formation in upper tract transitional cell carcinoma patients

Pfizer introduces four novel MMP-13 inhibitors as candidates for osteoarthritis treatment

IMPACT2 shows relief of hereditary angioedema attacks with C1-INH

Novel P-glycoprotein inhibitor is developed as an oral absorption enhancing agent

Novel compounds for the treatment of hepatitis C discovered by Bristol-Myers Squibb

Pfizer presents novel cholesteryl ester transfer protein inhibitors

Regeneron initiates phase III gout program with Arcalyst

Phase III ASA-404 trial in lung cancer extended to Japan

Advancell collaborates with Nobera to develop hand-foot syndrome treatment

Novel neutrophil elastase inhibitor shows efficacy in rat lung injury model

Abeille licenses AB-1001 to Prostrakan for North America and Europe

Cyclopamine analogues developed for cancer treatment

Emerflu pandemic influenza vaccine approved in Australia

Exenatide data analysis shows no increased risk of cardiovascular events

Trubion initiates phase I SBI-087 study in systemic lupus erythematosus

Roche completes tender offer for Genentech

RegeneRx presents phase II RGN-137 results in venous stasis

Neurotech reports phase II NT-501 results in dry AMD

Neurocrine reports top-line results from phase II elagolix trial in endometriosis

Novel histone deacetylase inhibitors claimed by Syndax Pharmaceuticals

Molecular Insight reports detailed phase II data for Zemiva

Recent Roche patent claims novel Raf kinase B and C inhibitors as antiproliferative agents

GlycoMimetics completes two phase I studies for GMI-1070

Novel monoamine reuptake inhibitors emerge from GlaxoSmithKline R&D

Interim results from phase II EC-145 trial reported by Endocyte

Acadia and Meiji Seika enter collaboration for procognitive drugs for schizophrenia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...